A 55-year-old woman with heart failure with reduced ejection fraction (HFrEF, EF 30%) on lisinopril and carvedilol presents with worsening dyspnea, orthopnea, and a 3 kg weight gain over 2 weeks. Physical exam shows elevated JVP, bilateral crackles, and peripheral edema. Serum sodium 128 mEq/L (normal 135–145), potassium 5.8 mEq/L (normal 3.5–5.0), creatinine 1.4 mg/dL (baseline 1.0). What is the most appropriate next step in management?

Explanation

## Clinical Scenario Interpretation This patient has: - **Acute decompensated HFrEF** with signs of pulmonary and systemic congestion - **Hyponatremia** (Na⁺ = 128 mEq/L) — likely dilutional from RAAS activation and ADH release - **Hyperkalemia** (K⁺ = 5.8 mEq/L) — concerning in context of ACE inhibitor use - **Worsening renal function** (Cr 1.0 → 1.4) — suggests cardiorenal syndrome - **No prior diuretic mentioned** — patient is not on loop diuretic therapy ## Acute Decompensation Management Hierarchy **Key Point:** In acute HFrEF decompensation, the immediate priority is **decongestion** with loop diuretics. Electrolyte abnormalities and neurohormonal optimization are secondary concerns that must not delay diuresis. ```mermaid flowchart TD A[Acute HFrEF decompensation]:::outcome --> B{Congestion present?}:::decision B -->|Yes| C[Initiate loop diuretic]:::action C --> D[Fluid restriction]:::action D --> E[Recheck electrolytes in 48-72 hrs]:::action E --> F{K+ normalized?}:::decision F -->|Yes| G[Consider aldosterone antagonist]:::action F -->|No| H[Hold K+-sparing agents]:::action B -->|No| I[Optimize neurohormonal blockade]:::action ``` ## Why Furosemide + Fluid Restriction is Correct 1. **Acute decompensation requires urgent decongestion** — loop diuretics are the only agents that rapidly reduce intravascular volume 2. **Hyponatremia is dilutional** — caused by excessive ADH and RAAS activation; it will improve with diuresis and fluid restriction, not with hypertonic saline 3. **Hyperkalemia is secondary** — caused by reduced renal perfusion and ACE inhibitor effect; it will improve once renal perfusion is restored via decongestion 4. **Fluid restriction (1 L/day)** — standard in HFrEF with hyponatremia; reduces ADH stimulus **High-Yield:** In HFrEF with hyponatremia + hyperkalemia + decompensation, **treat the congestion first**. Electrolyte abnormalities often self-correct once cardiac output and renal perfusion improve. ## Electrolyte Management Timeline | Abnormality | Cause | Immediate Action | Monitoring | |---|---|---|---| | Hyponatremia (128) | Dilutional (RAAS, ADH) | Diuresis + fluid restriction | Recheck Na⁺ at 48–72 hrs | | Hyperkalemia (5.8) | Reduced GFR + ACE-I | Improve renal perfusion via diuresis | Recheck K⁺ at 48–72 hrs | | Worsening Cr | Cardiorenal syndrome | Loop diuretic to restore perfusion | Trend Cr; do not escalate ACE-I | **Clinical Pearl:** Hyponatremia in HFrEF is a marker of neurohormonal activation and poor prognosis, but it is NOT an indication for hypertonic saline in the acute decompensated state. Hypertonic saline is reserved for severe symptomatic hyponatremia (Na⁺ < 120 with seizures) or chronic hyponatremia refractory to diuretics. **Warning:** Do NOT increase ACE inhibitor dose in the setting of rising creatinine and hyperkalemia. This will worsen both problems by further reducing glomerular filtration pressure.